HIV vaccine booster study for previous trial participants
Part of Immune system & allergy, Infections clinical trials.
This study tests a booster vaccine for HIV in people who were part of an earlier HIV vaccine trial. The goal is to see if it's safe and helps the immune system fight HIV better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier HVTN 706 HIV vaccine study, either as a vaccine or placebo recipient.
- You are between 18 and 60 years old.
- You are generally healthy, with no serious medical conditions or medications that affect immunity.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
- You are willing to have a lymph node biopsy (FNA) and follow study visits for about a year.
- You agree not to join another study with experimental agents while in this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This trial tests whether an experimental HIV vaccine, given with an adjuvant to boost the immune response, is safe and produces an immune response in infants who were exposed to HIV in the womb but are not infected. The study aims to help protect these vulnerable infants.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This study tests an experimental HIV vaccine that uses tiny particles and mRNA technology in healthy adults. If you qualify, you'll help researchers see if it's safe and if it triggers an immune response.
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
This study tests two booster doses of an HIV vaccine to see if they are safe and boost the immune system. It is for healthy adults who already received three earlier doses of a related vaccine.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.